Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coatomer protein complex subunit zeta-2 (COPZ2) is a small subunit of the coatomer protein complex (COPI), which contains seven subunits and is essential for the formation and function of COPI-type, non-clathrin-coated vesicles. COPI vesicles play a central role in retrograde transport from the Golgi back to the endoplasmic reticulum, specifically transporting dilysine-tagged proteins. In normal cellular physiology, COPZ2 is functionally redundant with its paralog COPZ1, allowing cells to tolerate loss or inhibition of one paralog. However, in certain cancers, COPZ2 is frequently silenced by epigenetic mechanisms, forcing tumor cells to depend solely on COPZ1 for maintaining Golgi integrity and vesicle trafficking. Aberrant silencing of COPZ2 can disrupt intracellular transport and contribute to tumorigenesis. Its altered expression and silencing have made it a potential component of prognostic gene signatures in some cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coatomer protein complex subunit zeta-2 (COPZ2).